St. Luke's Mountain State Tumor Institute

Boise, Idaho 83712

1 studies enrolling now · 2 studies all time

What they study most

Acute Lymphoblastic Leukemia, Lymphoma, Multiple Myeloma

Studies at this site

• Expanded Access Program (EAP) for Ciltacabtagene Autoleucel (Cilta-Cel) Out-of-Specification (OOS) in Participants With Multiple Myeloma — Available (expanded access)
• A Study of the Safety and Effectiveness of Apixaban in Preventing Blood Clots in Children With Leukemia Who Have a Central Venous Catheter and Are Treated With Asparaginase — Completed